[go: up one dir, main page]

WO1999036560A3 - Viral vectors encoding neurofilament light proteins and their use - Google Patents

Viral vectors encoding neurofilament light proteins and their use Download PDF

Info

Publication number
WO1999036560A3
WO1999036560A3 PCT/CA1999/000008 CA9900008W WO9936560A3 WO 1999036560 A3 WO1999036560 A3 WO 1999036560A3 CA 9900008 W CA9900008 W CA 9900008W WO 9936560 A3 WO9936560 A3 WO 9936560A3
Authority
WO
WIPO (PCT)
Prior art keywords
neurofilament light
viral vectors
vectors encoding
light proteins
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CA1999/000008
Other languages
French (fr)
Other versions
WO1999036560A2 (en
Inventor
Jean-Pierre Julien
Claude Gravel
Jurgen Meier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JULIEN JEAN PIERRE
Original Assignee
JULIEN JEAN PIERRE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JULIEN JEAN PIERRE filed Critical JULIEN JEAN PIERRE
Priority to AU19565/99A priority Critical patent/AU1956599A/en
Publication of WO1999036560A2 publication Critical patent/WO1999036560A2/en
Publication of WO1999036560A3 publication Critical patent/WO1999036560A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Novel viral vectors encoding neurofilament light proteins are described. The invention also provides methods of using these vectors in gene therapy to deliver neurofilament light proteins to subjects having neurodegenerative diseases, neural injuries, and neural degeneration due to aging.
PCT/CA1999/000008 1998-01-13 1999-01-13 Viral vectors encoding neurofilament light proteins and their use Ceased WO1999036560A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU19565/99A AU1956599A (en) 1998-01-13 1999-01-13 Viral vectors encoding neurofilament light proteins and their use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2220839 1998-01-13
CA2,220,839 1998-01-13

Publications (2)

Publication Number Publication Date
WO1999036560A2 WO1999036560A2 (en) 1999-07-22
WO1999036560A3 true WO1999036560A3 (en) 1999-09-30

Family

ID=4161756

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1999/000008 Ceased WO1999036560A2 (en) 1998-01-13 1999-01-13 Viral vectors encoding neurofilament light proteins and their use

Country Status (2)

Country Link
AU (1) AU1956599A (en)
WO (1) WO1999036560A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3668891B1 (en) * 2017-08-16 2023-07-26 Lgv1 S.R.L. Vtft isoform of a bpifb4 protein for use in neuronal deseases and injuries

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008026A1 (en) * 1992-09-25 1994-04-14 Rhone-Poulenc Rorer S.A. Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008026A1 (en) * 1992-09-25 1994-04-14 Rhone-Poulenc Rorer S.A. Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BETT ET AL: "DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309", VIRUS RESEARCH, vol. 39, no. 1, 1995, pages 75 - 82, XP002106222 *
JACOBS ET AL: "Recovery of Neurofilament Expression Selectively in Regenerating Reticulospinal Neurons", JOURNAL OF NEUROSCIENCE, vol. 17, no. 13, 1 July 1997 (1997-07-01), pages 5206 - 5220, XP002106229 *
KARPATI ET AL: "The principles of gene therapy for the nervous system", TRENDS IN NEUROSCIENCE, vol. 19, 1996, pages 49 - 54, XP002106220 *
MEIER J (REPRINT) ET AL: "In vivo alleviation of neurofilament swellings by viral mediated gene transfer.", MOLECULAR BIOLOGY OF THE CELL, (DEC 1996) VOL. 7, SUPP. [S], PP. 1263-1263A, XP002106218 *
ZHU ET AL: "Delayed Maturation of Regenerating Myelinated Axons in Mice Lacking Neurofilaments", EXPERIMENTAL NEUROLOGY, vol. 148, 1997, pages 299 - 316, XP002106228 *

Also Published As

Publication number Publication date
WO1999036560A2 (en) 1999-07-22
AU1956599A (en) 1999-08-02

Similar Documents

Publication Publication Date Title
WO2002069900A3 (en) Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
WO2000054813A3 (en) Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
WO2002024234A3 (en) Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
WO1998021343A8 (en) Genes encoding telomerase proteins
WO2000053776A3 (en) Human kallikrein-like genes
CA2336261A1 (en) Cyclin e2 genes and proteins
WO2002010388A3 (en) C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
AU7147898A (en) (dirofilaria) and (brugia) ankyrin proteins, nucleic acid molecules, and uses thereof
AU2002214542A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO1999036558A3 (en) Viral vectors encoding neurofilament heavy proteins and their use
WO1999036560A3 (en) Viral vectors encoding neurofilament light proteins and their use
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
AU2002258630A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002258617A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2001292326A1 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
AU2002245208A1 (en) Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
AU2002327214A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002324475A1 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002303137A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2003099863A3 (en) Resistin binding proteins, their preparation and use
AU2002254438A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
EP1383908A4 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
WO2002010199A3 (en) C3b/c4b complement receptor-like molecules and uses thereof
AU2001292647A1 (en) Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA